{
  "compound_id": "DB00801",
  "compound_name": "Halazepam",
  "compound_percentile": 0.161764705882353,
  "disease_id": "DOID:1312",
  "disease_name": "focal segmental glomerulosclerosis",
  "disease_percentile": 0.258127438231469,
  "metapath_contribution": {},
  "n_trials": 0.0,
  "prediction": 0.001063453651917,
  "status": 0
}